Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Desano Chemical Pharmaceuticals is a leading Chinese pharmaceutical company specializing in the development and large-scale manufacture of antiretroviral (ARV) drugs and active pharmaceutical ingredients (APIs). As a core subsidiary of the Acebright Pharmaceuticals Group, the company operates world-class manufacturing sites that are certified by the US FDA, EU GMP, and WHO-PQ. Desano is recognized as one of the largest global suppliers of HIV/AIDS medications, playing a pivotal role in international health programs by providing affordable generics to emerging markets. The company maintains strategic partnerships with the Medicines Patent Pool and major global pharmaceutical firms to license and produce essential treatments for HIV, Hepatitis, and COVID-19. Beyond its focus on infectious diseases, Desano provides comprehensive CDMO services and is expanding its research into oncology and other therapeutic areas. Its integrated business model spans from advanced chemical synthesis to the production of finished dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Desano Chemical Pharmaceuticals.